Articles from The Fly (April 8, 2024)

1-95 out of 95 article(s)

Title	Type	Words
1933 Industries to purchase 9% interest of cultivation, production subsidiary.		209
Alkermes presents results from long-term safety study of LYBALVI.		538
Amarin highlights key data on mechanistic insights into eicosapentaenoic acid.		366
Angi appoints Jeff Kip CEO.		202
Ascot Resources commences ore processing at Premier Gold Project.		231
Ashford Hospitality sees Q1 occupancy ~67%.		175
Auddia announces issuance of core AI patent.		221
Aura Minerals on track to achieve 2024 production view of 244,000-292,000 GEO.		455
Avant Brands to sell 45.75M units at 8.5c in private placement offering.		158
AZZ Inc. raises 2025 adjusted EPS view $4.50-$5.00 from $4.25-$4.75.		267
Bango reports 2023 revenue $46.1M vs. $28.5M last year.	Financial report	282
Biophytis launches OBA phase 2 clinical study in obesity with BIO101.		160
Black Diamond Therapeutics presents preclinical data on BDTX-1535 at AACR.		329
Blackstone to take AIR Communities private for $39.12 per share in cash.		155
Booz Allen, Cloudfare now delivering rapid incident response.		160
Bristol Myers: Krazati plus cetuximab showed ORR of 34%, PFS of 6.9 months.		230
Captivision enters partnership with Framework.		158
Cardiff presents data underscoring 'significant potential' of onvansertib.		221
Celularity data showing senescent cell elimination to be presented at ASGCT.		166
Century Therapeutics: Data from iPSC-derived cell therapy presented at AACR.		248
Chord Energy, Enerplus announce expiration of HSR Act waiting period.		233
Coeur Mining achieves commercial production at Rochester mine.		219
Collective Audience to acquire DSL Digital, terms not disclosed.		207
Core & Main to acquire Geothermal Supply Company, terms not disclosed.		199
CoreRx completes acquisition of Societal CDMO.		186
Data I/O announces major milestone with 500th PSV system sale.		180
Elevation Oncology presents preclinical proof-of concept data for HER3-ADC.		272
Eyenovia considers strategic alternatives, including possible sale.		334
Foremost Lithium provides update for drill program on Zoro Property.		230
FuelCell, EMTEC update, extend joint development agreement.		397
Graphjet Technology building agricultural waste-to-graphite production site.		163
Gritstone presents improvements to EDGE Platform at AACR 2024.		302
India Fund announces Rights Offering.		455
INmune Bio presents data on INB03's role as immune check point.		187
Inozyme announces 'positive' results from Phase 1/2 trials of INZ-701.		182
Iqvia, Salesforce expand global partnership.		260
Iris Energy: Poolside upsizes and extends AI cloud cervices contract.		166
Jaguar Health granted extension to regain Nasdaq compliance.		158
Johnson & Johnson announces presentation of findings on XARELTO.		249
Kineta presents data from Phase 1/2 VISTA-101 clinical trial at AACR.		293
Kymera Therapeutics announces presentation at AACR annual meeting.		434
Marker Therapeutics announces presentation on Phase 1 APOLLO study.		431
Market Action: Treasuries remain under water.		160
Market Update:.		160
Maxeon Solar reports preliminary Q4 revenue $229M, consensus $235.96M.	Financial report	169
Medtronic reports 'positive' trial, safety results from study of Sphere-360.	Clinical report	187
Melco announces extension of maturity date of revolving credit facilities.		151
Melco Resorts Finance announces proposed senior notes offering.		192
Mesa Labs announces amendment to credit facility, repurchase of notes.		236
Milestone: Etripamil 'effective' at restoring sinus rhythm in trial.		274
MiNK announces presentation of MiNK-215 data at AACR meeting.		210
Mullen Automotive initiates cost reduction, consolidation measures.		243
NextCure and LCB present data on B7-H4 antibody drug conjugate at AACR.		227
North Bay Resources to acquire 55.5% of Bishop Gold Mill.		281
Norwegian Cruise Line announces strategic long-term fleet expansion.		234
Nuvalent presents data on NVL-330, zidesamtinib at AACR.		255
Nuvectis says NXP900 demonstrates robust activity in NSCLC.		192
Ocugen: FDA clears IND amendment to initiate Phase 3 clinical trial of OCU400.		155
Oric Pharmaceuticals presents preclinical data on ORIC-944, ORIC-613.		465
Oryzon Genomics announces FDA clearance of IND to initiate Phase I/II trial.		184
Palatin presents results from Phase 3 PL9643 MELODY-1 trial.		448
Palladyne AI changes ticker symbol to PDYN.		159
Peapack-Private announces New York City expansion.		155
Perion Network sees Q1 revenue $157M, consensus $175.53M.	Financial report	272
Pineapple Energy urges shareholders to vote for reverse stock split.		388
Poseida: Phase 1 data supports potential of P-BCMA-ALLO1 therapy in MM.		260
R2 Semiconductor files new patent infringement lawsuit against Intel in France.		216
Renalytix announces financing with expected size up to $4M.		445
Revolution Medicines announces publications on discovery of RMC-7977.		483
Savaria acquires dumbwaiter, material lift assets of D.A. Matot.		156
ShockWave Medical data confirm consistent 'real-world' outcomes.		189
Silence Therapeutics says additional results from APOLLO phase 1 study published.		201
Skillz discloses non-compliance notice from Nasdaq.		196
Smart for Life to acquire Purely Optimal Nutrition, terms not disclosed.		196
Sono-Tek reports preliminary Q4 sales $4.8M vs $3.7M last year.	Financial report	264
Spirit Airlines to furlough approximately 260 pilots effective September 1.		178
Standard BioTools announces new solutions for Imaging Mass Cytometry workflow.		252
Studio City Finance announces tender offer for up to $100M of senior notes.		330
Supermicro announces new generation of IoT and embedded systems.		194
Supernus: FDA says SPN-830 NDA 'not ready for approval' in present form.		193
Syndax presents 'positive' results from AUGMENT-101 trial of Revumenib.		470
TechPrecision announces termination of agreement to acquire Votaw.		316
Theratechnologies announces data presentation of SORT1+ technology at AACR.		186
There is another heavy dose of Fedspeak.		214
Tracon Pharmaceuticals announces 1-for-20 reverse stock split.		222
Treasury Action: it's a quiet start to eclipse day.		181
Treasury Market Summary:.		197
Treasury supply heats up with.		182
Treasury's $140 B 3- and 6-month bill auctions were well received.		191
TScan Therapeutics appoints Chrysta Louis M.D CMO.		157
U Power to launch commercial operation for EV battery swapping system.		165
U.S. inflation releases dominated this week's calendar.		208
Vincerx: progress for VIP236 and VIP943 for solid tumors presented at AACR.		157
Vodafone, Infinite Reality showcase AI-Onboard at Mobile World Congress.		173
Xinwu District in China announces pledge of support for LOBO EV.		155